Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reduce Sedentary Behavior During Cancer Treatment - the RedSedCan Study

NCT06719206 is registered in ClinicalTrials.gov with Mälardalen University as lead sponsor.

NCT NCT06719206
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06719206 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reduce Sedentary Behavior During Cancer Treatment - the RedSedCan Study
Lead sponsor
Mälardalen University
Phase
Not applicable
Overall status
Recruiting
Start date
March 1, 2025
Completion date
December 31, 2030
Enrollment
210 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

adjuvant therapy, breast cancer, colorectal cancer (crc), neoadjuvant therapy, prostate cancer